GLP-1 therapy is a very effective and well-established treatment for T2D and obesity in clinic [7]; however, the molecular mechanisms of how GLP-1 is secreted in physiological nutrient condition is unclear. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.